CA
NZ
UK
AU
IND
US
American Bitcoin Corp (Nasdaq:ABTC) traded up approximately 9.12 percent in pre-market activity, near $7.06 versus Friday's close of $6.47. The move follows a regulatory filing showing that director Mateen Justin purchased shares of Class A Common Stock on both August 5 and August 6, …
Varex Imaging Corporation (Nasdaq:VREX), a leading designer and manufacturer of X-ray tubes, digital detectors, and imaging components used across medical and industrial applications, surged in pre-market trading after Teledyne Technologies Incorporated announced a definitive agreement to acquire the company for $18.90 per share in …
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX), a global biotechnology leader best known for its dominant cystic fibrosis franchise including KALYDECO, TRIKAFTA, and newer ALYFTREK, extended a rally that began last week following strong second quarterEarnings. The company reported revenue of $3.33 billion and raised full-year guidance …
AbCelleraBiologicsInc. (Nasdaq:ABCL), a clinical stage biotechnology company that discovers antibody based medicines using a proprietary AI powered platform, surged in pre-market trading after releasing anticipated top line Phase 2 data for ABCL635. The data showed the non hormonal therapy reduced moderate to severe hot …
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company known for pioneering mRNA based medicines including its widely distributed COVID-19 vaccine, traded higher in pre-market activity as investors responded to the FDA's approval of mFLUSIVA. The approval marks the company's first mRNA based seasonal flu vaccine and …
RadNet, Inc. (Nasdaq:RDNT), the largest provider of freestanding outpatient diagnostic imaging services in the United States, traded higher in pre-market activity following a second quarter report that beat expectations on nearly every measure. Revenue grew 25 percent year over year to $622.7 million, ahead …
Sionna Therapeutics, Inc. (Nasdaq:SION), a clinical stage biopharmaceutical company developing medicines that normalize the cystic fibrosis transmembrane conductance regulator protein, saw shares collapse following its second quarter update. The pipeline, which includes NBD1 stabilizers SION-719 and SION-451 alongside CFTR modulators galicaftor, SION-109, and SION-2851, …
Tenax Therapeutics, Inc. (Nasdaq:TENX), a Phase 3 clinical-stage specialty pharmaceutical company focused on cardiopulmonary therapies for unmet needs in the US and Canada, saw shares collapse in pre-market trading. The company's lead candidates, TNX-103 and TNX-102, have completed Phase III trials for pulmonary hypertension …
A wide set of industrial and industrial-linked names are trading near their 52-week highs this week, as second-quarter earnings results land across engineering and construction, industrial machinery, specialty materials, telecommunications infrastructure and commercial flooring. The breadth of the move spans several distinct end markets, …
Crude oil rose to around $79 a barrel on Monday, extending gains from the previous week as uncertainty over the Strait of Hormuz continued to support prices. Iran and Oman have yet to finalize an agreement to reopen the strategic waterway, and conflicting signals …
Please wait processing your request...